Volume 5 Number 3
Editorial
45
Pioneers, teachers and students: the ‘how-to’ of
cardiovascular interventionsEuroIntervention 2009;5:285-287
EAPCI column
47
Presidential Criss-Cross
The transfer of office between EAPCI presidentsEuroIntervention 2009;5:293-297
Focus article
48
How to set up an effective national primary angioplasty
network: lessons learned from five European countriesKnot J, Widimsky P, Wijns W, Stenestrand U, Kristensen S, van't Hof A, Weidinger F, Janzon M, Nörgaard B, Soerensen J, van de Wetering H, Thygesen K, Bergsten P, Digerfeldt C, Potgieter A, Tomer N, Fajadet J
EuroIntervention 2009;5:299-309
Clinical research
49
Biolimus-eluting biodegradable polymer versus sirolimuseluting
permanent polymer stent performance in long
lesions: results from the LEADERS multicentre trial substudyWykrzykowska J, Räber L, Ton de Vries T, Bressers M, Buszman P, Linke A, Ischinger T, Klauss V, Eberli F, Corti R, Wijns W, Morice M, Di Mario C, Regar E, Jüni P, Windecker S, Serruys PW
EuroIntervention 2009;5:310-317
50
One year outcome after primary stenting of infrapopliteal
lesions with the CHROMIS DEEP stent in the management of
critical limb ischaemiaEuroIntervention 2009;5:318-324
51
Predictive value of post-treatment platelet reactivity for
occurrence of post-discharge bleeding after non-ST
elevation acute coronary syndrome.EuroIntervention 2009;5:325-329
53
Serum catalytic iron as a novel biomarker of vascular
injury in acute coronary syndromesEuroIntervention 2009;5:336-342
54
Nationwide trends in the utilisation of percutaneous
coronary intervention (PCI) in the United States of America
based on gender and ethnicitiesEuroIntervention 2009;5:343-348
55
Predictors of angiographic restenosis after drug eluting
stents in the coronary arteries: contemporary practice in
real world patientsRathore S, Terashima M, Katoh O, Matsuo H, Tanaka N, Kinoshita Y, Kimura M, Tuschikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T
EuroIntervention 2009;5:349-354
56
Angiographic and intravascular ultrasound findings following
implantation of the Endeavor™ zotarolimus-eluting stents in
patients from the real-world clinical practiceFeres R, Andrade P, Costa R, De Ribamar Costa J, Abizaid A, Staico R, Tanajura L, Siqueira D, Maia J, Lasave L, Sousa A, Sousa J
EuroIntervention 2009;5:355-362
57
Difference of culprit plaque composition between patients
with and without pre-infarction angina: an intravascular
ultrasound radiofrequency analysisHigashikuni Y, Tanabe K, Tanimoto S, Aoki J, Yamamoto H, Nakazawa G, Chihara R, Onuma Y, Otsuki S, Yagishita A, Yachi S, Nakajima H, Hara K
EuroIntervention 2009;5:363-369
58
Rotational atherectomy followed by drug-eluting stent
implantation in calcified coronary lesionsFuruichi S, Sangiorgi G, Godino C, Airoldi F, Montorfano M, Chieffo A, Michev I, Carlino M, Colombo A
EuroIntervention 2009;5:370-374
Expert review
59
Impact of single or multicentre study design on the results
of trials examining the efficacy of adjunctive devices to
prevent distal embolisation during acute myocardial
infarctionEuroIntervention 2009;5:375-383
60
Efficacy of Cilostazol in reducing restenosis in patients
undergoing contemporary stent based PCI: a meta-analysis
of randomised controlled trialsEuroIntervention 2009;5:384-393
Technical report
Volume 5 Number 3 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Cordis, a Johnson & Johnson company
- Daiichi Sankyo
- Hexacath
- Medtronic
- Terumo



